REPORT ID 7132

Global High Performance Active Pharmaceutical Ingredients (HPAPI) Market Research Report 2017

Publish Date
2-Nov-17
Pages
118
Format
Electronic (PDF)

In this report, the global High Performance Active Pharmaceutical Ingredients (HPAPI) market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of High Performance Active Pharmaceutical Ingredients (HPAPI) in these regions, from 2012 to 2022 (forecast), covering
    North America
    Europe
    China
    Japan
    Southeast Asia
    India
Global High Performance Active Pharmaceutical Ingredients (HPAPI) market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including
    Bristol-Myers Squibb
    Novartis
    Sanofi Aventis
    Pfizer
    Lonza
    Novasep
    Hospira
    BASF
    Merck
    Bayer
    Teva Pharmaceuticals
    Boehringer Ingelheim
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
    Synthetic Ingredients
    Biological Ingredients
    Others
On the basis of the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate for each application, including
    Oncology
    Glaucoma
    Anti-diabetic
    Cardiovascular
    Musculoskeletal
    Hormonal
    Others

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

Global High Performance Active Pharmaceutical Ingredients (HPAPI) Market Research Report 2017
1 High Performance Active Pharmaceutical Ingredients (HPAPI) Market Overview
    1.1 Product Overview and Scope of High Performance Active Pharmaceutical Ingredients (HPAPI)
    1.2 High Performance Active Pharmaceutical Ingredients (HPAPI) Segment by Type (Product Category)
        1.2.1 Global High Performance Active Pharmaceutical Ingredients (HPAPI) Production and CAGR (%) Comparison by Type (Product Category)(2012-2022)
        1.2.2 Global High Performance Active Pharmaceutical Ingredients (HPAPI) Production Market Share by Type (Product Category) in 2016
        1.2.3 Synthetic Ingredients
        1.2.4 Biological Ingredients
        1.2.5 Others
    1.3 Global High Performance Active Pharmaceutical Ingredients (HPAPI) Segment by Application
        1.3.1 High Performance Active Pharmaceutical Ingredients (HPAPI) Consumption (Sales) Comparison by Application (2012-2022)
        1.3.2 Oncology
        1.3.3 Glaucoma
        1.3.4 Anti-diabetic
        1.3.5 Cardiovascular
        1.3.6 Musculoskeletal
        1.3.7 Hormonal
        1.3.8 Others
    1.4 Global High Performance Active Pharmaceutical Ingredients (HPAPI) Market by Region (2012-2022)
        1.4.1 Global High Performance Active Pharmaceutical Ingredients (HPAPI) Market Size (Value) and CAGR (%) Comparison by Region (2012-2022)
        1.4.2 North America Status and Prospect (2012-2022)
        1.4.3 Europe Status and Prospect (2012-2022)
        1.4.4 China Status and Prospect (2012-2022)
        1.4.5 Japan Status and Prospect (2012-2022)
        1.4.6 Southeast Asia Status and Prospect (2012-2022)
        1.4.7 India Status and Prospect (2012-2022)
    1.5 Global Market Size (Value) of High Performance Active Pharmaceutical Ingredients (HPAPI) (2012-2022)
        1.5.1 Global High Performance Active Pharmaceutical Ingredients (HPAPI) Revenue Status and Outlook (2012-2022)
        1.5.2 Global High Performance Active Pharmaceutical Ingredients (HPAPI) Capacity, Production Status and Outlook (2012-2022)

2 Global High Performance Active Pharmaceutical Ingredients (HPAPI) Market Competition by Manufacturers
    2.1 Global High Performance Active Pharmaceutical Ingredients (HPAPI) Capacity, Production and Share by Manufacturers (2012-2017)
        2.1.1 Global High Performance Active Pharmaceutical Ingredients (HPAPI) Capacity and Share by Manufacturers (2012-2017)
        2.1.2 Global High Performance Active Pharmaceutical Ingredients (HPAPI) Production and Share by Manufacturers (2012-2017)
    2.2 Global High Performance Active Pharmaceutical Ingredients (HPAPI) Revenue and Share by Manufacturers (2012-2017)
    2.3 Global High Performance Active Pharmaceutical Ingredients (HPAPI) Average Price by Manufacturers (2012-2017)
    2.4 Manufacturers High Performance Active Pharmaceutical Ingredients (HPAPI) Manufacturing Base Distribution, Sales Area and Product Type
    2.5 High Performance Active Pharmaceutical Ingredients (HPAPI) Market Competitive Situation and Trends
        2.5.1 High Performance Active Pharmaceutical Ingredients (HPAPI) Market Concentration Rate
        2.5.2 High Performance Active Pharmaceutical Ingredients (HPAPI) Market Share of Top 3 and Top 5 Manufacturers
        2.5.3 Mergers & Acquisitions, Expansion

3 Global High Performance Active Pharmaceutical Ingredients (HPAPI) Capacity, Production, Revenue (Value) by Region (2012-2017)
    3.1 Global High Performance Active Pharmaceutical Ingredients (HPAPI) Capacity and Market Share by Region (2012-2017)
    3.2 Global High Performance Active Pharmaceutical Ingredients (HPAPI) Production and Market Share by Region (2012-2017)
    3.3 Global High Performance Active Pharmaceutical Ingredients (HPAPI) Revenue (Value) and Market Share by Region (2012-2017)
    3.4 Global High Performance Active Pharmaceutical Ingredients (HPAPI) Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.5 North America High Performance Active Pharmaceutical Ingredients (HPAPI) Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.6 Europe High Performance Active Pharmaceutical Ingredients (HPAPI) Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.7 China High Performance Active Pharmaceutical Ingredients (HPAPI) Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.8 Japan High Performance Active Pharmaceutical Ingredients (HPAPI) Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.9 Southeast Asia High Performance Active Pharmaceutical Ingredients (HPAPI) Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.10 India High Performance Active Pharmaceutical Ingredients (HPAPI) Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

4 Global High Performance Active Pharmaceutical Ingredients (HPAPI) Supply (Production), Consumption, Export, Import by Region (2012-2017)
    4.1 Global High Performance Active Pharmaceutical Ingredients (HPAPI) Consumption by Region (2012-2017)
    4.2 North America High Performance Active Pharmaceutical Ingredients (HPAPI) Production, Consumption, Export, Import (2012-2017)
    4.3 Europe High Performance Active Pharmaceutical Ingredients (HPAPI) Production, Consumption, Export, Import (2012-2017)
    4.4 China High Performance Active Pharmaceutical Ingredients (HPAPI) Production, Consumption, Export, Import (2012-2017)
    4.5 Japan High Performance Active Pharmaceutical Ingredients (HPAPI) Production, Consumption, Export, Import (2012-2017)
    4.6 Southeast Asia High Performance Active Pharmaceutical Ingredients (HPAPI) Production, Consumption, Export, Import (2012-2017)
    4.7 India High Performance Active Pharmaceutical Ingredients (HPAPI) Production, Consumption, Export, Import (2012-2017)

5 Global High Performance Active Pharmaceutical Ingredients (HPAPI) Production, Revenue (Value), Price Trend by Type
    5.1 Global High Performance Active Pharmaceutical Ingredients (HPAPI) Production and Market Share by Type (2012-2017)
    5.2 Global High Performance Active Pharmaceutical Ingredients (HPAPI) Revenue and Market Share by Type (2012-2017)
    5.3 Global High Performance Active Pharmaceutical Ingredients (HPAPI) Price by Type (2012-2017)
    5.4 Global High Performance Active Pharmaceutical Ingredients (HPAPI) Production Growth by Type (2012-2017)

6 Global High Performance Active Pharmaceutical Ingredients (HPAPI) Market Analysis by Application
    6.1 Global High Performance Active Pharmaceutical Ingredients (HPAPI) Consumption and Market Share by Application (2012-2017)
    6.2 Global High Performance Active Pharmaceutical Ingredients (HPAPI) Consumption Growth Rate by Application (2012-2017)
    6.3 Market Drivers and Opportunities
        6.3.1 Potential Applications
        6.3.2 Emerging Markets/Countries

7 Global High Performance Active Pharmaceutical Ingredients (HPAPI) Manufacturers Profiles/Analysis
    7.1 Bristol-Myers Squibb
        7.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.1.2 High Performance Active Pharmaceutical Ingredients (HPAPI) Product Category, Application and Specification
            7.1.2.1 Product A
            7.1.2.2 Product B
        7.1.3 Bristol-Myers Squibb High Performance Active Pharmaceutical Ingredients (HPAPI) Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.1.4 Main Business/Business Overview
    7.2 Novartis
        7.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.2.2 High Performance Active Pharmaceutical Ingredients (HPAPI) Product Category, Application and Specification
            7.2.2.1 Product A
            7.2.2.2 Product B
        7.2.3 Novartis High Performance Active Pharmaceutical Ingredients (HPAPI) Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.2.4 Main Business/Business Overview
    7.3 Sanofi Aventis
        7.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.3.2 High Performance Active Pharmaceutical Ingredients (HPAPI) Product Category, Application and Specification
            7.3.2.1 Product A
            7.3.2.2 Product B
        7.3.3 Sanofi Aventis High Performance Active Pharmaceutical Ingredients (HPAPI) Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.3.4 Main Business/Business Overview
    7.4 Pfizer
        7.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.4.2 High Performance Active Pharmaceutical Ingredients (HPAPI) Product Category, Application and Specification
            7.4.2.1 Product A
            7.4.2.2 Product B
        7.4.3 Pfizer High Performance Active Pharmaceutical Ingredients (HPAPI) Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.4.4 Main Business/Business Overview
    7.5 Lonza
        7.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.5.2 High Performance Active Pharmaceutical Ingredients (HPAPI) Product Category, Application and Specification
            7.5.2.1 Product A
            7.5.2.2 Product B
        7.5.3 Lonza High Performance Active Pharmaceutical Ingredients (HPAPI) Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.5.4 Main Business/Business Overview
    7.6 Novasep
        7.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.6.2 High Performance Active Pharmaceutical Ingredients (HPAPI) Product Category, Application and Specification
            7.6.2.1 Product A
            7.6.2.2 Product B
        7.6.3 Novasep High Performance Active Pharmaceutical Ingredients (HPAPI) Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.6.4 Main Business/Business Overview
    7.7 Hospira
        7.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.7.2 High Performance Active Pharmaceutical Ingredients (HPAPI) Product Category, Application and Specification
            7.7.2.1 Product A
            7.7.2.2 Product B
        7.7.3 Hospira High Performance Active Pharmaceutical Ingredients (HPAPI) Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.7.4 Main Business/Business Overview
    7.8 BASF
        7.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.8.2 High Performance Active Pharmaceutical Ingredients (HPAPI) Product Category, Application and Specification
            7.8.2.1 Product A
            7.8.2.2 Product B
        7.8.3 BASF High Performance Active Pharmaceutical Ingredients (HPAPI) Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.8.4 Main Business/Business Overview
    7.9 Merck
        7.9.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.9.2 High Performance Active Pharmaceutical Ingredients (HPAPI) Product Category, Application and Specification
            7.9.2.1 Product A
            7.9.2.2 Product B
        7.9.3 Merck High Performance Active Pharmaceutical Ingredients (HPAPI) Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.9.4 Main Business/Business Overview
    7.10 Bayer
        7.10.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.10.2 High Performance Active Pharmaceutical Ingredients (HPAPI) Product Category, Application and Specification
            7.10.2.1 Product A
            7.10.2.2 Product B
        7.10.3 Bayer High Performance Active Pharmaceutical Ingredients (HPAPI) Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.10.4 Main Business/Business Overview
    7.11 Teva Pharmaceuticals
    7.12 Boehringer Ingelheim

8 High Performance Active Pharmaceutical Ingredients (HPAPI) Manufacturing Cost Analysis
    8.1 High Performance Active Pharmaceutical Ingredients (HPAPI) Key Raw Materials Analysis
       8.1.1 Key Raw Materials
       8.1.2 Price Trend of Key Raw Materials
       8.1.3 Key Suppliers of Raw Materials
       8.1.4 Market Concentration Rate of Raw Materials
    8.2 Proportion of Manufacturing Cost Structure
       8.2.1 Raw Materials
       8.2.2 Labor Cost
       8.2.3 Manufacturing Expenses
    8.3 Manufacturing Process Analysis of High Performance Active Pharmaceutical Ingredients (HPAPI)

9 Industrial Chain, Sourcing Strategy and Downstream Buyers
    9.1 High Performance Active Pharmaceutical Ingredients (HPAPI) Industrial Chain Analysis
    9.2 Upstream Raw Materials Sourcing
    9.3 Raw Materials Sources of High Performance Active Pharmaceutical Ingredients (HPAPI) Major Manufacturers in 2015
    9.4 Downstream Buyers

10 Marketing Strategy Analysis, Distributors/Traders
    10.1 Marketing Channel
        10.1.1 Direct Marketing
        10.1.2 Indirect Marketing
        10.1.3 Marketing Channel Development Trend
    10.2 Market Positioning
        10.2.1 Pricing Strategy
        10.2.2 Brand Strategy
        10.2.3 Target Client
    10.3 Distributors/Traders List

11 Market Effect Factors Analysis
    11.1 Technology Progress/Risk
        11.1.1 Substitutes Threat
        11.1.2 Technology Progress in Related Industry
    11.2 Consumer Needs/Customer Preference Change
    11.3 Economic/Political Environmental Change

12 Global High Performance Active Pharmaceutical Ingredients (HPAPI) Market Forecast (2017-2022)
    12.1 Global High Performance Active Pharmaceutical Ingredients (HPAPI) Capacity, Production, Revenue Forecast (2017-2022)
        12.1.1 Global High Performance Active Pharmaceutical Ingredients (HPAPI) Capacity, Production and Growth Rate Forecast (2017-2022)
        12.1.2 Global High Performance Active Pharmaceutical Ingredients (HPAPI) Revenue and Growth Rate Forecast (2017-2022)
        12.1.3 Global High Performance Active Pharmaceutical Ingredients (HPAPI) Price and Trend Forecast (2017-2022)
    12.2 Global High Performance Active Pharmaceutical Ingredients (HPAPI) Production, Consumption , Import and Export Forecast by Region (2017-2022)
        12.2.1 North America High Performance Active Pharmaceutical Ingredients (HPAPI) Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
        12.2.2 Europe High Performance Active Pharmaceutical Ingredients (HPAPI) Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
        12.2.3 China High Performance Active Pharmaceutical Ingredients (HPAPI) Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
        12.2.4 Japan High Performance Active Pharmaceutical Ingredients (HPAPI) Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
        12.2.5 Southeast Asia High Performance Active Pharmaceutical Ingredients (HPAPI) Production, Revenue, Consumption, Export and I